ANGO position history
The shares of Angiodynamics (ANGO) that First Eagle Investment Management, LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 218,369 shares, $1.3M, <0.01% of portfolio, New
- 2024 Q3: 394,114 shares, $3.1M, <0.01% of portfolio, Add +80.5%
- 2024 Q4: 410,335 shares, $3.8M, <0.01% of portfolio, Add +4.1%
- 2025 Q1: 377,835 shares, $3.5M, <0.01% of portfolio, Reduce −7.9%
- 2025 Q2: 305,335 shares, $3M, <0.01% of portfolio, Reduce −19.2%
- 2025 Q3: 277,335 shares, $3.1M, <0.01% of portfolio, Reduce −9.2%
- 2025 Q4: 267,735 shares, $3.4M, <0.01% of portfolio, Reduce −3.5%
- 2026 Q1: 551,470 shares, $6.3M, <0.01% of portfolio, Add +106.0%
- 2026 Q2: 276,435 shares, $3.6M, <0.01% of portfolio, Reduce −49.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|